Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2013
11/27/2013CN103405525A Composition and medicine for strengthening heart and preventing and curing chronic heart failure and preparation method
11/27/2013CN103405514A Antihypertensive pillow with medicine inside
11/27/2013CN103405508A Method for extracting oestrogen active ingredients in cistanche
11/27/2013CN103405502A Drug for treating hemiplegia and preparation method thereof
11/27/2013CN103405501A Preparation method of three-component blood-activating and stasis-dissolving capsules
11/27/2013CN103405498A Compound lipid-lowering pills
11/27/2013CN103405467A Application of theanine, tea polysaccharide and Rubus Suavissmus S, Lee extract as aldose reductase inhibitor
11/27/2013CN103405461A Applications of salicin
11/27/2013CN103405442A Pharmaceutical composition of salvia miltiorrhiza extractive, and use thereof
11/27/2013CN103405438A Application of trapidil or its pharmaceutically acceptable salts in preparation of pulmonary hypertension controlling medicines
11/27/2013CN103405434A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitor and application thereof
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/27/2013CN103405430A Applications of corynoxine
11/27/2013CN103405429A VEGFR-2 (Vascular Endothelial Growth Factor Receptor-2) inhibitors and use thereof
11/27/2013CN103405408A Application of chrysin in preparation of medicines for treating cerebral arterial thrombosis
11/27/2013CN103405405A Compositions and methods of delivery of pharmacological agents
11/27/2013CN103405404A Novel use of dimethyloxalglycine and mesenchymal stem cell separation method
11/27/2013CN103405403A Prescription for treating haemorrhoids
11/27/2013CN103405398A Allantoin preparation and application thereof
11/27/2013CN103405394A Metoprolol tartrate sustained release tablet and preparation method thereof
11/27/2013CN103405390A Preparation method of lecithin-bound iodine enteric-coated pellet tablet
11/27/2013CN103083270B Xanthophyll chewable tablet
11/27/2013CN102994334B Life-nourishing balsam pear yellow wine
11/27/2013CN102727823B Medicine for postoperative rehabilitation of cerebral hemorrhage
11/27/2013CN102716241B Traditional Chinese medicine preparation for treating piles
11/27/2013CN102670935B Method for extracting total saponins from allium chinense
11/27/2013CN102670630B Medicinal composition capsules of valsartand hydrochlorothiazide and preparation method for capsules
11/27/2013CN102579511B Method for integrally extracting steroidal compounds, polysaccharides and polyphenols from inonotus obliquus
11/27/2013CN102558298B Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers
11/27/2013CN102526523B Traditional Chinese medicine for treating myocardial ischemia
11/27/2013CN102516397B Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine
11/27/2013CN102512656B Quinapril hydrochloride medicinal composition
11/27/2013CN102512392B Manidipine hydrochloride solid dispersion, preparation and preparation method of above
11/27/2013CN102488765B Medicine for treating osseous rheumatism and cerebral apoplexy
11/27/2013CN102399266B Immunogenic peptide of humvoltage-gated potassium channel 1.5 (hKv1.5) and purpose thereof
11/27/2013CN102387800B Rosuvastatin and atorvastatin derivatives
11/27/2013CN102247339B Application of isoliquiritigenin to preparation of drugs with vasodilatation function
11/27/2013CN101918362B 吡啶衍生物 Pyridine derivatives
11/27/2013CN101632650B Self-microemulsifying semisolid skeleton capsule of daidzein and preparation method thereof
11/26/2013US8592433 Compounds and compositions as protein kinase inhibitors
11/26/2013US8591950 Hydrogel implants with varying degrees of crosslinking
11/26/2013CA2610361C Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control
11/26/2013CA2561565C Methods for repression of phospholamban gene and modulating cardiac contractility
11/26/2013CA2469472C Endothelial stem cells, populations, methods of isolation and use thereof
11/26/2013CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/26/2013CA2429839C Compositions for preventing or ameliorating multiple risk factor syndromes
11/26/2013CA2378562C Method for producing oligopolysaccharides
11/26/2013CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013WO2013173778A1 Methods for treating or predicting risk of a ventricular tachyarrhythmia event
11/21/2013WO2013173647A1 Compositions and methods for modulating apoa1 and abca1 expression
11/21/2013WO2013173417A2 Glucokinase activator compositions for the treatment of diabetes
11/21/2013WO2013173370A1 Small molecule inhibitors of rna binding motif (rbm) proteins for the treatment of acute cellular injury
11/21/2013WO2013172999A1 Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
11/21/2013WO2013172344A1 Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity c-reactive protein
11/21/2013WO2013171752A1 Compositions and methods for inducing angiogenesis
11/21/2013WO2013171694A1 Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists
11/21/2013WO2013171318A1 Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists
11/21/2013WO2013170862A1 Substrate mediated enzymes prodrug therapy
11/21/2013WO2013170778A1 Intermediate compound for preparing ambrisentan, preparing method thereof, and preparing method of ambrisentan
11/21/2013WO2013170769A1 Pharmaceutical composition for regulating blood lipids and uses thereof
11/21/2013WO2013170741A1 Benzodioxane compound, composition comprising same and use thereof
11/21/2013WO2013170738A1 Agomelatine acid radical composite, and preparation method and application thereof
11/21/2013WO2013170317A1 Liquid formulation
11/21/2013WO2013149258A3 Compositions and methods for treating or preventing metabolic syndrome disorders
11/21/2013WO2013127782A3 Use of micro-rnas or genes as markers for the identification, diagnosis and therapy of individual forms of non-ischemic cardiomyopathies or storage diseases of the heart
11/21/2013WO2012169897A8 Weight reducing material
11/21/2013US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310321 Diagnostic agent for ischemic heart disease risk group
11/21/2013US20130309313 Compositions and Methods for Increasing the Stability of Food Product Additives
11/21/2013US20130309289 Drug Delivery From Stents
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309215 Pharmaceutical composition
11/20/2013EP2664328A1 Omega3 fatty acid compound preparation
11/20/2013EP2663304A1 Combination therapy
11/20/2013EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease
11/20/2013EP2272869B1 Angiopoietin-2 specific binding agents
11/20/2013EP2251337B1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
11/20/2013EP2112151B1 Haloaryl substituted aminopurines for use in treatment
11/20/2013EP2108655B1 Immune-modulating peptide
11/20/2013EP2085078B1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof
11/20/2013EP1847244B1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
11/20/2013EP1683520B1 Water-soluble prodrugs
11/20/2013CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
11/20/2013CN103402986A Modulators of S1P receptors
11/20/2013CN103402971A Nicotinic receptor non-competitive antagonists
11/20/2013CN103402534A Therapeutic method for treating congestive heart failure
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103397052A Endothelial progenitor cell with highly-expressed human CXCR7 (C-X-C chemokine receptor 7) gene as well as preparation method and application of endothelial progenitor cell
11/20/2013CN103397040A Recombinant plant-derived antihypertensive peptide
11/20/2013CN103396521A Synthesis and micellization application of amphiphilic beta-cyclodextrin star polymer
11/20/2013CN103396492A Human platelet collagen receptor resistant human-derived monoclonal antibody fragment and application thereof
11/20/2013CN103396474A APJ receptor compound
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN103396399A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising same
11/20/2013CN103396368A Application of free radical of nitroxide to treatment of ischemia reperfusion injury
11/20/2013CN103396299A Novel flavonoid compounds and application thereof in preparation of drug for resisting ischemic heart disease
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1595